Nano News
Looking inside NanoliveRevolutionizing lipid droplet analysis: insights from Nanolive’s Smart Lipid Droplet Assay Application Note
Introducing the Smart Lipid Droplet Assay: A breakthrough in label-free lipid droplet analysis Discover the power of Nanolive's Smart Lipid Droplet Assay (SLDA), the first smart digital assay to provide a push-button solution for analyzing lipid droplet dynamics,...
Food additives and gut health: new research from the University of Sydney
The team of Professor Wojciech Chrzanowski in the Sydney Pharmacy School at the University of Sydney have published their findings on the toxic effect of titanium nanoparticles found in food. The paper “Impact of nano-titanium dioxide extracted from food products on...
2023 scientific publications roundup
2023 has been a record year for clients using the Nanolive system in their scientific publications. The number of peer-reviewed publications has continued to increase, and there has been a real growth in groups publishing pre-prints to give a preview of their work....
Closer to understanding coronavirus: Research results with Institut Pasteur
Nanolive is proud to be part of a research collaboration with leading virologists from the group of Olivier Schwartz at the Institut Pasteur in Paris. The latest research from Nanolive’s Deep Quantitative Biology department and the Institut Pasteur uses cutting-edge...
Nanolive is exhibiting at the ASCB I EMBO Meeting, Cell Bio 2023. December 3 – 5 in Boston
Presentation Nanolive is delighted to invite you to attend our upcoming presentation at the Cell Bio Meeting in Boston on December 4, 2023, from 10:15am to 11:00am in Theatre 1. During our talk, “High-content label-free imaging for live phenotypic insights and...
Demo site inauguration at University of San Francisco
Nanolive is delighted to invite you for an upcoming exclusive in-person event at UC San Francisco, on November 17th, 2023, from 11.00am to 1.00pm. Nanolive delivers breakthrough label-free live cell and phenotypic solutions that combine screening, imaging and analysis...
Nanolive is exhibiting during the ESMO Congress 2023 October 20 – 23 in Madrid, Spain
💫Visit our booth:The world’s leading cancer research minds will converge at the ESMO Congress 2023. We are thrilled to announce that Nanolive will be exhibiting there from October 20 to 23, at Booth #560 in Hall 5! Come and meet our team and discover the...
Nanolive is attending the ELRIG Drug Discovery 2023 Conference October 18 – 19 in Liverpool, UK
Presentation Nanolive is delighted to invite you to attend our upcoming presentation at the ELRIG Drug Discovery 2023 Conference in Liverpool on October 18, 2023, from 16:15 to 16:30 in Auditorium 1. During our talk, “A powerful solution for high content label-free...
Seminar @ University of Stanford with Nanolive
Label-free live cell and phenotypic analysis solutions Nanolive is delighted to invite you to the Stanford Seminar with Nanolive at Stanford University, on October 30th, 2023, from 1:30pm to 3:00pm. Nanolive delivers breakthrough label-free live cell and phenotypic...
Nanolive at the SPS Annual Meeting September 18-20
Joint presentation with Sanofi Nanolive is delighted to invite for you to attend our upcoming joint presentation with Sanofi at the Safety Pharmacology Society (SPS) Annual Meeting in Brussels on September 20, 2023, from 12:30 PM to 1:30 PM in Studio 214. During our...
Webinar – High content in vitro imaging for translational success: targeted therapies
Nanolive hosts this event on "Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules". In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity...
Nanolive empowers groundbreaking ferroptosis research published in Nature
Congratulations to the Conrad lab for their latest Nature paper 'Phase separation of FSP1 promotes ferroptosis'! This beautiful capture published as part of the paper provides new information about the events leading up to ferroptotic cell death. Using refractive...
New possibilities for potent cancer immunotherapies with Nanolive solutions
We are thrilled to announce a groundbreaking scientific study authored by Mathieu Frechin and Daniel Olive, in collaboration with Aix Marseille Université, ImCheck therapeutics, and Nanolive. Their remarkable research on Vγ9Vδ2 T cells has opened up new possibilities...
The first push-button and automated solution for profiling cell health, death, apoptosis and necrosis, label-free
On June 20th, Nanolive has launched another ground-breaking tool in cell analysis: the LIVE Cytotoxicity Assay, an AI-powered digital assay with fluorescent labelling that monitors the responses of different cell lines in co-culture simultaneously. For this event, we...
Nanolive launches the 3D Cell Explorer 96focus: A game-changing solution for label-free phenotypic screening and analysis
Nanolive, a leading provider of high content label-free live cell imaging and analysis solutions, has announced the launch of the 3D Cell Explorer 96focus, an innovative platform that brings unlimited high content analysis to label-free live cell imaging without the...
17 new scientific publications featuring Nanolive technology
Since the start of the year, 17 more papers have been published using Nanolive imaging, featuring an incredibly broad range of cell types; stem cells, adipocytes, neurons, osteoblasts, neutrophils, melanocytes, e. coli, primary synoviocytes, and several cancer cell...
Nanolive imaging confirms success of mesoestetic’s new treatment at the subcellular level
We are happy to see that Nanolive imaging has been used to confirm the success of another new therapy, this time treating melasma. In their latest paper “Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved...
Mitochondrial secretion captured by Nanolive’s live cell imaging in new Cell Metabolism Paper
Congratulations to scientists at Seoul National University who have recently published their work in Cell Metabolism in their article “Mitochondrial fragmentation and donut formation enhance mitochondrial secretion to promote osteogenesis”! The authors characterized...